Clinical Trial Update: International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma [Phase 1]

View source ↗

Summary

An international Phase I trial is evaluating dinutuximab beta in combination with VDC/IE chemotherapy for GD2-positive Ewing sarcoma. The study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• dinutuximab beta (dinutuximab beta)

Snippet

Sponsor: Prof. Dr. Dirk Reinhardt | Conditions: High-risk GD2-Positive Ewing Sarcoma | Phase 1 | Status: NOT_YET_RECRUITING